Monaco Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)
Condition:   Rheumatoid ArthritisIntervention:   Sponsor:   Hoffmann-La RocheTerminated - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 16, 2012 Category: Research Source Type: clinical trials

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)
Condition:   Rheumatoid ArthritisIntervention:   Sponsor:   Hoffmann-La RocheTerminated - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 16, 2012 Category: Research Source Type: clinical trials

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)
Condition:   Rheumatoid ArthritisIntervention:   Sponsor:   Hoffmann-La RocheTerminated - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 16, 2012 Category: Research Source Type: clinical trials

A Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)
Condition:   Rheumatoid ArthritisIntervention:   Sponsor:   Hoffmann-La RocheTerminated - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 16, 2012 Category: Research Source Type: clinical trials